David J. Bartlett

David J. Bartlett

Auto-generated profile, based on publicly available information

David J. Bartlett

Department of Radiology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2023 in Radiology: Imaging Cancer
Verified
Journal Article
Closed access
BBBrian J. Burkett
Brian J. Burkett
DBDavid J. Bartlett
David J. Bartlett
PMPatrick W. McGarrah
Patrick W. McGarrah
ALAkeem R. Lewis
Akeem R. Lewis
DJDerek Richard Johnson
Derek Richard Johnson
AKAyse T. Kendi
Ayse T. Kendi
Theranostics is the combination of two approaches-diagnostics and therapeutics-applied for decades in cancer imaging using radiopharmaceuticals or paired radiopharmaceuticals to image and selectively treat various cancers. The clinical use of theranostics has increased in recent years, with U.S. Food and Drug Administration (FDA) approval of lutetium 177 (177Lu) tetraazacyclododecane tetraacetic acid octreotate (DOTATATE) and 177Lu-prostate-specific membrane antigen vector-based radionuclide therapies. The field of theranostics has imminent potential for emerging clinical applications. This article reviews critical areas of active clinical advancement in theranostics, including forthcoming clinical trials advancing FDA-approved and emerging radiopharmaceuticals, approaches to dosimetry calculations, imaging of different radionuclide therapies, expanded indications for currently used theranostic agents to treat a broader array of cancers, and emerging ideas in the field. Keywords: Molecular Imaging, Molecular Imaging-Cancer, Molecular Imaging-Clinical Translation, Molecular Imaging-Target Development, PET/CT, SPECT/CT, Radionuclide Therapy, Dosimetry, Oncology, Radiobiology © RSNA, 2023.

4 January 2019 in Abdominal Radiology
Verified
Journal Article
Closed access
PDF file
DBDavid J. Bartlett
David J. Bartlett
PTPaul G. Thacker
Paul G. Thacker
Travis E GrotzTravis E Grotz
Travis E Grotz
RGRondell P. Graham
Rondell P. Graham
JFJoel G. Fletcher
Joel G. Fletcher
SSShannon P. Sheedy
Shannon P. Sheedy

27 September 2018 in Abdominal Radiology
Verified
Journal Article
Closed access
PDF file
SSShannon P. Sheedy
Shannon P. Sheedy
DBDavid J. Bartlett
David J. Bartlett
ALAmy L. Lightner
Amy L. Lightner
STSteven W. Trenkner
Steven W. Trenkner
DBDavid H. Bruining
David H. Bruining
JFJoel G. Fletcher
Joel G. Fletcher

1 November 2025 in RadioGraphics
Verified
Journal Article
Closed access
SHSafa Hoodeshenas
Safa Hoodeshenas
JDJonathan R Dillman
Jonathan R Dillman
STStuart A. Taylor
Stuart A. Taylor
JRJordi Rimola
Jordi Rimola
BTBachir Taouli
Bachir Taouli
JFJoel G. Fletcher
Joel G. Fletcher
Because of a renewed focus on diagnostic and prognostic imaging biomarkers of small bowel strictures in Crohn disease, radiologists can use CT and MR enterography to identify these biomarkers to diagnose and measure strictures, especially those at high risk for surgery.

1 November 2024 in RadioGraphics
Verified
Journal Article
Closed access
MHMelina Hosseiny
Melina Hosseiny
PKParisa Khoshpouri
Parisa Khoshpouri
TCThurl Cledera
Thurl Cledera
MBMaria Lucia Brun-Vergara
Maria Lucia Brun-Vergara
FAFernanda Avalos
Fernanda Avalos
DBDavid J. Bartlett
David J. Bartlett

30 January 2025 in American Journal of Gastroenterology
Verified
Journal Article
Closed access
SMShuji Mitsuhashi
Shuji Mitsuhashi
CGChinmay Guralwar
Chinmay Guralwar
DBDavid Bartlett
David Bartlett
NTNaoki Takahashi
Naoki Takahashi
SMShounak Majumder
Shounak Majumder
SVSanthi Swaroop Vege
Santhi Swaroop Vege
An abstract is unavailable. This article is available as a PDF only.